Gotowe bibliografie tematyczne / Lymphocyte therapy

Spis treści

  1. Artykuły w czasopismach
  2. Rozprawy doktorskie
  3. Książki
  4. Części książek
  5. Streszczenia konferencji
  6. Raporty organizacyjne

Gotowa bibliografia na temat „Lymphocyte therapy”

Autor: Grafiati
Data publikacji: 2 czerwca 2025
Data aktualizacji: 31 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Lymphocyte therapy”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Lymphocyte therapy"

1

Silverman, David A., and Dennis J. Chapron. "Lymphopenic Effect of Carbamazepine in a Patient with Chronic Lymphocytic Leukemia." Annals of Pharmacotherapy 29, no. 9 (1995): 865–67. http://dx.doi.org/10.1177/106002809502900906.

Pełny tekst źródła
Streszczenie:
Objective: To report a dramatic and reproducible suppressive effect of carbamazepine on circulating lymphocytes in an elderly woman with chronic lymphocytic leukemia. Case Summary: An elderly woman taking phenytoin for a stroke-associated seizure disorder had lymphocyte count of 28 800 × 106 cells/L. Speculating an unusual lymphadenopathic effect of the phenytoin therapy, carbamazepine therapy was substituted. After 15 weeks of carbamazepine treatment, the lymphocyte count declined to 3200 × 106 cells/L. Because of severe diarrhea, carbamazepine therapy was stopped and phenytoin therapy was re
Style APA, Harvard, Vancouver, ISO itp.
2

Broughan, Thomas A., Rafael Valenzuela, Eduardo Escorcia, Michelle Secic, and David P. Vogt. "Mouse antibody‐coated lymphocytes during OKT3 therapy in liver transplantation." Clinical Transplantation 8, no. 5 (1994): 488–91. http://dx.doi.org/10.1111/j.1399-0012.1994.tb00275.x.

Pełny tekst źródła
Streszczenie:
Flow cytometry has been a technique in search of a use in transplantation. With each new monoclonal antibody, it has been hoped that the secrets of rejection would be unlocked. The usefulness of CD3+ T‐ lymphocyte counts to predict successful treatment of organ transplant rejection has been called into question. CD2+, CD3+, and mouse antibody‐coated CD3 lymphocytes were followed by flow cytometry in 44 liver transplant patients during OKT3 therapy for induction or rejection. CD3+ lymphocyte counts did not predict successful management of rejection by OKT3. When expressed as percentages of the
Style APA, Harvard, Vancouver, ISO itp.
3

Gokce, Aksanur, Tulay Omma, Mustafa Çelikc, and Işılay Taşkaldıran. "An overview of the hematological picture with antithyroid therapy in Graves' disease." Acta Facultatis Medicae Naissensis 39, no. 4 (2022): 467–75. http://dx.doi.org/10.5937/afmnai39-36192.

Pełny tekst źródła
Streszczenie:
Aim: Graves' disease is an autoimmune thyroid disease that is the most common cause of hyperthyroidism. Peripheral blood cell parameters such as neutrophils, lymphocytes, and platelets play a role in inflammation control. Several studies have proven that neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio and platelet-lymphocyte ratio are indicators of chronic subclinical inflammation in various diseases. In our study, we aimed to review the peripheral blood picture by evaluating these parameters before and after antithyroid treatment in patients with Graves' disease. Patients and methods:
Style APA, Harvard, Vancouver, ISO itp.
4

Culver, Kenneth W., W. French Anderson, and R. Michael Blaese. "Lymphocyte Gene Therapy." Human Gene Therapy 2, no. 2 (1991): 107–9. http://dx.doi.org/10.1089/hum.1991.2.2-107.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Prabowo, Rangsang Bagus, Dewi Indah Noviana Pertiwi, and FX Hendriyono. "CD4 LYMPHOCYTE IN HIV / AIDS BEFORE AND AFTER ANTIRETROVIRAL THERAPY." Berkala Kedokteran 13, no. 2 (2017): 183. http://dx.doi.org/10.20527/jbk.v13i2.4074.

Pełny tekst źródła
Streszczenie:
Abstract: Human Immunodefficiency Virus (HIV) is a virus that decreases the human immunity system, therefore the infected people become susceptible to any kind of infections. Examination of CD4 lymphocyte count periodically is one of the antiretroviral therapy success indicators. The purpose of this research was to determine the difference of CD4 lymphocyte count before and after antiretroviral therapy at Ulin General Hospital Banjarmasin on 2013-2015. The method of this research was observational analytic with cross-sectional approach. The study population was 55 patients which were selected
Style APA, Harvard, Vancouver, ISO itp.
6

Lissoni, Paolo, Sandro Barni, Marco Andres, et al. "Lymphocytosis Decline is not Responsible for Tumor Progression in Cancer Patients Chronically Treated with Interleukin-2." Tumori Journal 80, no. 4 (1994): 283–85. http://dx.doi.org/10.1177/030089169408000408.

Pełny tekst źródła
Streszczenie:
Aims and background The antitumor activity of IL-2 is mediated by an increase in lymphocyte number. Moreover, our previous studies have shown that therapy for 1 week/month with low-dose subcutaneous IL-2 is sufficient to maintain high levels of lymphocytes in cancer patient who have had tumor regression or stable disease (SD) in response to IL-2 immunotherapeutic cycles. This study was performed to establish whether tumor progression in cancer patients chronically treated with IL-2 may be associated with lymphocyte number decline. Methods The study included 53 metastatic renal cell cancer pati
Style APA, Harvard, Vancouver, ISO itp.
7

Zeremski, Vanja, Aleksandar Savic, Vesna Cemerikic-Martinovic, Ivana Milosevic, Marina Dragicevic, and Farra El. "The case of T-cell large granular lyphocyte leukemia presented as transfusion dependent anemia with sustained response to cyclosporine a therapy: Case report." Medical review 69, no. 11-12 (2016): 376–78. http://dx.doi.org/10.2298/mpns1612376z.

Pełny tekst źródła
Streszczenie:
Case report. A 41-year-old man presented with anemia, lymphocytosis and splenomegaly. T-cell large granular lymphocyte leukemia was diagnosed based on lymphocytosis of T-cell large granular lymphocytes, characteristic immunophenotype (CD3+, CD8+, CD16+, CD57+) of the lymphocytes and clonally rearranged T-cell receptor genes. Therapy indication was transfusion-dependent anemia. Initial cyclosporine therapy and low-dose oral methotrexate failed to control anemia and lymphocytosis. Yet, a complete clinical and hematological response (without molecular remission) was achieved and sustained when cy
Style APA, Harvard, Vancouver, ISO itp.
8

Francis, G., L. Kappos, P. O’Connor, et al. "Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy." Multiple Sclerosis Journal 20, no. 4 (2013): 471–80. http://dx.doi.org/10.1177/1352458513500551.

Pełny tekst źródła
Streszczenie:
Background: Reduction in peripheral blood lymphocytes is an expected pharmacodynamic outcome of fingolimod therapy. Objective: The objective of this article is to evaluate lymphocyte dynamics during and after fingolimod therapy and assess the relationship between lymphocyte counts and infections. Methods: Lymphocyte counts and their relationship with infections were evaluated in three multiple sclerosis (MS) populations: (Group A) FREEDOMS phase 3 core study group ( n = 1272); (Group B) All Studies group (one phase 2 and two phase 3 studies, plus their extensions; n = 2315); and (Group C) Foll
Style APA, Harvard, Vancouver, ISO itp.
9

Chen, Yang, Yanyan Xie, Min Ruan та Jinning Shi. "The Levels of T Lymphocyte Subsets in Immune Thrombocytopenia Associated with Anti-GPIIb/IIIa- and/or Anti-GPIbα-Mediated Responses Are Differentially Sensitive to Dexamethasone". Acta Haematologica 140, № 1 (2018): 60–66. http://dx.doi.org/10.1159/000491977.

Pełny tekst źródła
Streszczenie:
Objective: The aim of this work was to investigate the influence of T lymphocyte subsets and platelet-specific autoantibodies on immune thrombocytopenia (ITP) with dexamethasone therapy. Methods: The samples were obtained from patients before therapy. T lymphocyte subsets were measured by flow cytometry, and platelet-specific autoantibodies were evaluated by modified monoclonal antibody immobilization of platelet antigen assay. Results: A total of 50 ITP patients were involved in the study. Twenty-three were anti-GPIbα antibody positive and were treated with dexamethasone, with a response rate
Style APA, Harvard, Vancouver, ISO itp.
10

von Roemeling, Christina, Jeet Patel, Savannah Carpenter, et al. "EXTH-48. ADENO-ASSOCIATED VIRUS TARGETING OF THE TUMOR MICROENVIRONMENT TO IMPROVE LYMPHOCYTE RECRUITMENT IN GLIOBLASTOMA." Neuro-Oncology 26, Supplement_8 (2024): viii247—viii248. http://dx.doi.org/10.1093/neuonc/noae165.0979.

Pełny tekst źródła
Streszczenie:
Abstract BACKGROUND Glioblastoma (GBM) is notoriously devoid of lymphocytes driven in part by a paucity of lymphocyte trafficking factors necessary to prompt their recruitment, infiltration, and activation. We have developed a novel recombinant adeno-associated virus (AAV) gene therapy strategy that enables focal and stable reconstitution of the GBM tumor microenvironment (TME) with C-X-C motif ligand 9 (CXCL9), a powerful call-and-receive chemokine for cytotoxic T lymphocytes (CTLs). By increasing lymphocyte recruitment in GBM, we HYPOTHESIZE that these tumors will be more responsive to immun
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Lymphocyte therapy"

1

CARRIGLIO, NICOLA. "Preclinical gene therapy studies, altered lymphocyte development and function in ADA-SCID." Doctoral thesis, Università degli Studi di Roma "Tor Vergata", 2012. http://hdl.handle.net/2108/209654.

Pełny tekst źródła
Streszczenie:
Genetic defects in the adenosine deaminase (ADA) gene are among the most common causes for severe combined immunodeficiency (SCID). ADA-SCID patients suffer from lymphopenia, absent cellular and humoral immunity, recurrent infections and autoimmune manifestations in milder forms. Currently available therapeutic options for this otherwise fatal disorder include bone marrow transplantation (BMT), enzyme replacement therapy with bovine ADA (PEG-ADA) or hematopoietic stem cell gene therapy (GT). The overall aims of my this thesis were to evaluate the preclinical safety of HSC gene therapy a
Style APA, Harvard, Vancouver, ISO itp.
2

Debant, Marjolaine. "Etude de la dérégulation des entrées calciques du lymphocyte B de leucémie lymphoïde chronique : mise en évidence d'une nouvelle piste thérapeutique." Thesis, Brest, 2017. http://www.theses.fr/2017BRES0150.

Pełny tekst źródła
Streszczenie:
La leucémie lymphoïde chronique (LLC) constitue l'hémopathie maligne la plus fréquente dans les pays occidentaux et résulte d’une accumulation de lymphocytes B (LB) monoclonaux matures porteurs de la glycoprotéine CD5. Les LB de LLC sont également caractérisées par une altération de l'homéostasie du calcium avec, d'une part, la mise en évidence de facteurs de survie contrôlés par le calcium tels que phospho-ERK, NFAT-2 et IL-10, et d'autre part par une progression de la maladie qui est associée à la réponse au calcium. Tout d'abord, afin de mieux comprendre l'impact de la molécule CD5 sur les
Style APA, Harvard, Vancouver, ISO itp.
3

De, Milito Angelo. "Immune activation during HIV-1 infection : implication for B cell dysfunctions and therapy monitoring /." Stockholm, 2002. http://diss.kib.ki.se/2002/91-7349-170-5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Martens, Lawrence S. A. "The effects of exogenous 5-aminolevulinic acid-induced protoporphyrin IX photodynamic therapy on human lymphocyte cell-mediated cytotoxicity." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp04/mq20670.pdf.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Coque, Emmanuelle. "La neuroimmunité dans la sclérose latérale amyotrophique." Thesis, Montpellier, 2017. http://www.theses.fr/2017MONTT095.

Pełny tekst źródła
Streszczenie:
La sclérose latérale amyotrophique (SLA) est une maladie neurodégénérative incurable caractérisée par la perte sélective des motoneurones du cerveau et de la moelle épinière. Elle se manifeste par une faiblesse musculaire qui évolue vers une paralysie, entrainant la mort du patient dans les 3 à 5 ans après l’apparition des symptômes. Une réponse inflammatoire associée à l'accumulation de cellules immunitaire dans le système nerveux central (SNC) est une signature de la SLA. Ce travail propose d'étudier le rôle des cellules résidentes du SNC, notamment les astrocytes, et des cellules immunitair
Style APA, Harvard, Vancouver, ISO itp.
6

Momin, Mohammad Yahya [Verfasser], and Udo [Akademischer Betreuer] Bakowsky. "Polymeric Photosensitizer Nanocomplex Encapsulated T-lymphocyte Delivery System for Photodynamic Therapy of Cancer / Mohammad Yahya Momin ; Betreuer: Udo Bakowsky." Marburg : Philipps-Universität Marburg, 2017. http://d-nb.info/1130323080/34.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Ngandu, Jean Pierre Kabue. "Coreceptor expression and T lymphocyte subset distribution in HIV-infected and TB co-infected South African patients on anti-retroviral therapy." Thesis, Stellenbosch : University of Stellenbosch, 2009. http://hdl.handle.net/10019.1/2219.

Pełny tekst źródła
Streszczenie:
Thesis (MScMedSc (Pathology. Medical Virology))--University of Stellenbosch, 2009.<br>ENGLISH ABSTRACT: In 2007, AIDS caused an estimated 2.1 millions deaths worldwide; about 70% in sub-Saharan Africa. HIV preferentially targets activated CD4 T cells, expressing the major HIV receptor CD4, as well as the major chemokine coreceptors CCR5 and CXCR4. These coreceptors play a prominent role during HIV cell entrance phase, HIV transmission and also disease progression. They have been found to be differentially expressed by CD4 T cell subsets. Tuberculosis coinfection may enhance immune activat
Style APA, Harvard, Vancouver, ISO itp.
8

Cha, Esther. "MARRYING IMMUNOTHERAPY AND CHEMOTHERAPY: A CANCER THERAPY BASED ON T LYMPHOCYTE EXPANSION AUGMENTED BY ALTERNATE GAMMA CHAIN CYTOKINES AND GEMCITABINE-MEDIATED INHIBITION OF MYELOID DERIVED SUPPRESSOR CELLS." VCU Scholars Compass, 2009. http://scholarscompass.vcu.edu/etd/1905.

Pełny tekst źródła
Streszczenie:
Successful adoptive immunotherapy (AIT) for cancer relies on the infusion of in vitro expanded, tumor-reactive lymphocytes with a goal of generating productive tumor immunity. Previously, our lab has developed a protocol to activate selectively tumor-reactive T lymphocytes in vitro using two pharmacologic agents, bryostatin-1 and ionomycin. Following the pharmacological stimulation, conventionally, IL-2 is added to stimulate in vitro proliferation. In this report, alternate cytokines from the common cytokine receptor γ-chain family, namely IL-7 and IL-15, were explored as the alternative cytok
Style APA, Harvard, Vancouver, ISO itp.
9

Bartolo, Laurent. "Réponses immunitaires et induction de tolérance pour la thérapie génique rAAV du muscle basée sur le ciblage des hépatocytes : induction de tolérance et mécanismes immunitaires liés à la transduction des hépatocytes Liver-based tolerance induction of CD8+ and CD4+ T cells responses in rAAV muscle gene therapy." Thesis, Sorbonne Paris Cité, 2018. http://www.theses.fr/2018USPCB198.

Pełny tekst źródła
Streszczenie:
Les réponses immunes contre les traitements de thérapie génique rAAV, dirigées non seulement contre la capside du vecteur, mais aussi contre le transgène, représentent un défi majeur en particulier dans le contexte d'un transfert de gènes vers le muscle pour le traitement de diverses maladies monogéniques du muscle. Cette thèse est focalisée sur la réponse dirigée contre le transgène. Celle-ci se met en place contre des éléments du transgène thérapeutique qui ne sont pas initialement présents, ou insuffisamment exprimés, chez l'hôte et peut entraîner l'élimination des cellules qui produisent l
Style APA, Harvard, Vancouver, ISO itp.
10

El-Sawy, Tarek. "THE MECHANISM AND IMPACT OF EARLY POST-TRANSPLANT INFLAMMATION ON THE ACTIVATION STATE, DOWN-STREAM T LYMPHOCYTE INFILTRATION, AND ESTABLISHMENT OF PROLONGED SURVIVAL OF AN ALLOGRAFT WITH CO-STIMULATION BLOCKADE THERAPY." Connect to online version, 2004. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=case1087393648.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Lymphocyte therapy"

1

Raut, Mohan, and Mugdha Raut. Lymphocyte Immunization Therapy (LIT) in Reproductive Failures. Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-2960-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Alexander, Michael A. Immune-based cancer treatment: The T lymphocyte response. CRC Press, 2011.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Jean-Marie, Andrieu, Lu Wei, and International Symposium on Cellular Approaches to the Control of HIV Disease (1st : 1994 : Paris, France), eds. Cell activation and apoptosis in HIV infection: Implications for pathogenesis and therapy. Plenum Press, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Alexander, Michael A. Immune-based cancer treatment: The T lymphocyte response. CRC Press, 2011.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

1933-, Koldovksy P., ed. Lymphocytes in immunotherapy of cancer. Springer-Verlag, 1989.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Hancock, Sarah. Fludarabine as first line therapy for chronic lymphocytic leukaemia. University of Birmingham, Department of Public Health and Epidemiology, 2003.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Chadi, Nabhan, ed. Chronic lymphocytic leukemia research focus. Nova Science Publishers, 2006.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

1956-, Zhang Jingwu, and Cohen Irun R, eds. T-cell vaccination. Nova Biomedical Books, 2008.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

I, Gabrilovich Dmitry, and Hurwitz Arthur A, eds. Tumor-induced immune suppression: Mechanisms and therapeutic reversal. Springer, 2008.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

C, Hyde, National Co-ordinating Centre for HTA (Great Britain), and Health Technology Assessment Programme, eds. Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: A technology assessment. Core Research on behalf of the NCCHTA, 2002.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Lymphocyte therapy"

1

Johnson, Jeffrey E., Velvet R. Van Ryan, and Arkadiusz Z. Dudek. "Tumor-Infiltrating Lymphocyte (TIL) Therapy." In The Basics of Cancer Immunotherapy. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-59475-5_4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Raut, Mohan, and Mugdha Raut. "Introduction to Lymphocyte Immunization Therapy (LIT)." In Lymphocyte Immunization Therapy (LIT) in Reproductive Failures. Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-2960-1_6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Sanna, M., R. Pistis, R. Faedda, et al. "Variations in T Lymphocyte Subsets in IgA Nephropathy." In Current Therapy in Nephrology. Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-0865-2_15.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Gentry, Tracy. "T Lymphocyte Based HIV Gene Therapy Strategies." In Gene Therapy for HIV Infection. Springer Berlin Heidelberg, 1998. http://dx.doi.org/10.1007/978-3-662-11821-4_5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Lamperi, S., S. Carozzi, and M. G. Nasini. "Calcium Antagonists Prevent Lymphocyte Activation in Kidney Allograft Recipients." In Current Therapy in Nephrology. Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-0865-2_127.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Raut, Mohan, and Mugdha Raut. "Introduction to Reproductive Immunology and Reproductive Failure." In Lymphocyte Immunization Therapy (LIT) in Reproductive Failures. Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-2960-1_1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Raut, Mohan, and Mugdha Raut. "Recent Meta-Analyses and LIT." In Lymphocyte Immunization Therapy (LIT) in Reproductive Failures. Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-2960-1_13.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Raut, Mohan, and Mugdha Raut. "Safety of LIT." In Lymphocyte Immunization Therapy (LIT) in Reproductive Failures. Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-2960-1_10.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Raut, Mohan, and Mugdha Raut. "Controversies About LIT: REMIS Study." In Lymphocyte Immunization Therapy (LIT) in Reproductive Failures. Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-2960-1_11.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Raut, Mohan, and Mugdha Raut. "Mechanism of Action of LIT." In Lymphocyte Immunization Therapy (LIT) in Reproductive Failures. Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-2960-1_8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Lymphocyte therapy"

1

Hubel, Allison, and Jeffrey McCullough. "Cryopreservation of Cultured Blood Cells for Use in Gene Therapy and Immunotherapy." In ASME 1997 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 1997. http://dx.doi.org/10.1115/imece1997-1318.

Pełny tekst źródła
Streszczenie:
Abstract The freezing characteristics of genetically manipulated lymphocytes and hematopoietic stem cells were studied. The water transport characteristics of stem cells which had been cultured and transduced with a therapeutic gene were different from that of a freshly isolated cells. Changes in the freezing characteristics for genetically transformed lymphocytes were also observed. Specifically, cryopreservation protocols developed for the fresh peripheral blood lymphocytes do not produce comparable survival rates for lymphocytes which have been cultured and transduced. These results indicat
Style APA, Harvard, Vancouver, ISO itp.
2

Gee, A. P. "Hematopoietic Stem Cell Engineering: The Magic Bullet of the Next Millenium?" In ASME 1997 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 1997. http://dx.doi.org/10.1115/imece1997-1317.

Pełny tekst źródła
Streszczenie:
Abstract Hematopoietic stem cell [HSC] therapy has its origins as hematological rescue following marrow ablative high-dose therapy for refractory cancers and myelodysplastic syndromes. In its simplest form, bone marrow is collected from a tissue-matched related normal donor and intravenously infused into the patient who has usually received high-dose chemo/radiotherapy for his or her disease. The stem cells migrate to the marrow spaces, where they multiply and differentiate to restore blood cell-forming activity and immune defenses in the recipient Restrictions in the availability of tissue-ma
Style APA, Harvard, Vancouver, ISO itp.
3

Vainagii, O. M. "Microscopic changes in the lymphocyte densities of lymphatic nodes under the action of He-Ne laser radiation." In Low-Level Laser Therapy, edited by Tatiana I. Solovieva. SPIE, 2001. http://dx.doi.org/10.1117/12.425527.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Ferreira, Raquel, Sara Ganhão, Salomé Garcia, et al. "AB1312 TIME-COURSE CHANGE OF NEUTROPHIL-LYMPHOCYTE RATIO, MONOCYTE-LYMPHOCYTE RATIO AND PLATELET-LYMPHOCYTE RATIO IN PSORIATIC ARTHRITIS PATIENTS AND RESPONSE TO BIOLOGIC THERAPY." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.2875.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Sökücü, Sinem Nedime, Cengiz Özdemir, Senay Aydın, Seda Tural Önür, and Kaan Kara. "Effect of CPAP therapy on neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with obstructive sleep apnea." In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa2275.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Guzmán-Guzmán, Iris Paola, Oscar Zaragoza-García, José Eduardo Navarro-Zarza, and Isela Parra-Rojas. "AB0254 NEUTROPHIL-LYMPHOCYTE RATIO AND PLATELET-LYMPHOCYTE RATIO IN PATIENTSRECEIVING ANTIRHEUMATIC THERAPY: RELATIONSHIP TO CLINICAL AND LABORATORY MARKERS OF DISEASE ACTIVITY." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.7762.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Ismail, R., B. Balakrishnan, S. Hegab, and Z. Smith. "Pulmonary Arterial Hypertension Caused by Cytotoxic T-Lymphocyte-Associated Protein 4 Inhibitor Therapy." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3603.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Yousef, I., Z. L. Dorey-Stein, A. B. Karanam, S. Tittaferrante, T. Buckey, and K. V. Shenoy. "Can Neutrophil to Lymphocyte Ratio Predict Response to Biological Therapy in Severe Uncontrolled Asthma?" In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1462.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Laing, Christian E., Quanyuan He, Tony Collins, et al. "900 TBio BFX 4101: a neoantigen prioritization pipeline for selected tumor-infiltrating lymphocyte therapy." In SITC 38th Annual Meeting (SITC 2023) Abstracts. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/jitc-2023-sitc2023.0900.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Niu, Wenjuan, Hong-Yan Wen, Shi Qiao, et al. "AB0031 IL-2 THERAPY AFFECT PERIPHERAL BLOOD LYMPHOCYTE LEVEL IN PATIENTS WITH PRIMARY SJöGREN’S SYNDROME." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.7175.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Lymphocyte therapy"

1

Strube, Randall. Anti-HER2/Toxin Expressing Lymphocytes for Breast Cancer Therapy. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada395157.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Strobe, Randall. Anti-HER2/Toxin Expressing Lymphocytes for Breast Cancer Therapy. Defense Technical Information Center, 2000. http://dx.doi.org/10.21236/ada393070.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Lymphocyte therapy” dla poszczególnych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii